These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

257 related items for PubMed ID: 8122366

  • 41. Identification of a novel glucocorticoid response element within the genome of the human immunodeficiency virus type 1.
    Soudeyns H, Geleziunas R, Shyamala G, Hiscott J, Wainberg MA.
    Virology; 1993 Jun; 194(2):758-68. PubMed ID: 7684876
    [Abstract] [Full Text] [Related]

  • 42. Expression of interleukin 10 in B lymphocytes of different origin.
    Finke J, Ternes P, Lange W, Mertelsmann R, Dölken G.
    Leukemia; 1993 Nov; 7(11):1852-7. PubMed ID: 7694007
    [Abstract] [Full Text] [Related]

  • 43. Influence of Burkitt's lymphoma and primary B cells on latent gene expression by the nonimmortalizing P3J-HR-1 strain of Epstein-Barr virus.
    Rooney C, Howe JG, Speck SH, Miller G.
    J Virol; 1989 Apr; 63(4):1531-9. PubMed ID: 2538644
    [Abstract] [Full Text] [Related]

  • 44. fgr proto-oncogene mRNA induced in B lymphocytes by Epstein-Barr virus infection.
    Cheah MS, Ley TJ, Tronick SR, Robbins KC.
    Nature; 1989 Apr; 319(6050):238-40. PubMed ID: 3003578
    [Abstract] [Full Text] [Related]

  • 45. Selective induction of allostimulatory capacity after 5-azaC treatment of EBV carrying but not EBV negative Burkitt lymphoma cell lines.
    Cuomo L, Trivedi P, de Campos-Lima PO, Zhang QJ, Ragnar E, Klein G, Masucci MG.
    Mol Immunol; 1993 Apr; 30(5):441-50. PubMed ID: 7681932
    [Abstract] [Full Text] [Related]

  • 46. B cell-specific activation of the Epstein-Barr virus-encoded C promoter compared with the wide-range activation of the W promoter.
    Contreras-Brodin B, Karlsson A, Nilsson T, Rymo L, Klein G.
    J Gen Virol; 1996 Jun; 77 ( Pt 6)():1159-62. PubMed ID: 8683201
    [Abstract] [Full Text] [Related]

  • 47. Parallel existence of Epstein-Barr virus (EBV) positive and negative cells in a sporadic case of Burkitt lymphoma.
    Trivedi P, Zhang QJ, Chen F, Minarovits J, Ekman M, Biberfeld P, Klein G, Winberg G.
    Oncogene; 1995 Aug 03; 11(3):505-10. PubMed ID: 7630634
    [Abstract] [Full Text] [Related]

  • 48. Resistance to TGF-beta1 correlates with a reduction of TGF-beta type II receptor expression in Burkitt's lymphoma and Epstein-Barr virus-transformed B lymphoblastoid cell lines.
    Inman GJ, Allday MJ.
    J Gen Virol; 2000 Jun 03; 81(Pt 6):1567-78. PubMed ID: 10811940
    [Abstract] [Full Text] [Related]

  • 49. Differences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitt's lymphoma cells.
    Rowe M, Rowe DT, Gregory CD, Young LS, Farrell PJ, Rupani H, Rickinson AB.
    EMBO J; 1987 Sep 03; 6(9):2743-51. PubMed ID: 2824192
    [Abstract] [Full Text] [Related]

  • 50. Restricted Epstein-Barr virus protein expression in Burkitt lymphoma is due to a different Epstein-Barr nuclear antigen 1 transcriptional initiation site.
    Sample J, Brooks L, Sample C, Young L, Rowe M, Gregory C, Rickinson A, Kieff E.
    Proc Natl Acad Sci U S A; 1991 Jul 15; 88(14):6343-7. PubMed ID: 1648738
    [Abstract] [Full Text] [Related]

  • 51. Three transcriptionally distinct forms of Epstein-Barr virus latency in somatic cell hybrids: cell phenotype dependence of virus promoter usage.
    Kerr BM, Lear AL, Rowe M, Croom-Carter D, Young LS, Rookes SM, Gallimore PH, Rickinson AB.
    Virology; 1992 Mar 15; 187(1):189-201. PubMed ID: 1310556
    [Abstract] [Full Text] [Related]

  • 52. Retinoic acid induces changes in c-fgr proto-oncogene mRNA levels in Burkitt's lymphoma cells.
    Faulkner L, Katz DR, Brickell PM.
    Immunobiology; 1993 Aug 15; 188(4-5):460-8. PubMed ID: 8244449
    [Abstract] [Full Text] [Related]

  • 53. Expression of tumor-associated epitopes on Epstein-Barr virus-immortalized B-cells and Burkitt's lymphomas transfected with epithelial mucin complementary DNA.
    Jerome KR, Bu D, Finn OJ.
    Cancer Res; 1992 Nov 01; 52(21):5985-90. PubMed ID: 1382849
    [Abstract] [Full Text] [Related]

  • 54. Epstein-Barr virus nuclear antigen 2 activates transcription of the terminal protein gene.
    Zimber-Strobl U, Suentzenich KO, Laux G, Eick D, Cordier M, Calender A, Billaud M, Lenoir GM, Bornkamm GW.
    J Virol; 1991 Jan 01; 65(1):415-23. PubMed ID: 1845900
    [Abstract] [Full Text] [Related]

  • 55. Redefining the Epstein-Barr virus-encoded nuclear antigen EBNA-1 gene promoter and transcription initiation site in group I Burkitt lymphoma cell lines.
    Schaefer BC, Strominger JL, Speck SH.
    Proc Natl Acad Sci U S A; 1995 Nov 07; 92(23):10565-9. PubMed ID: 7479841
    [Abstract] [Full Text] [Related]

  • 56. The cytogenetics of human B lymphoid malignancy: studies in Burkitt's lymphoma and Epstein-Barr virus-transformed lymphoblastoid cell lines.
    Steel CM, Morten JE, Foster E.
    IARC Sci Publ; 1985 Nov 07; (60):265-92. PubMed ID: 2998993
    [Abstract] [Full Text] [Related]

  • 57. Retinoic acid induces persistent, RARalpha-mediated anti-proliferative responses in Epstein-Barr virus-immortalized b lymphoblasts carrying an activated C-MYC oncogene but not in Burkitt's lymphoma cell lines.
    Cariati R, Zancai P, Quaia M, Cutrona G, Giannini F, Rizzo S, Boiocchi M, Dolcetti R.
    Int J Cancer; 2000 May 01; 86(3):375-84. PubMed ID: 10760826
    [Abstract] [Full Text] [Related]

  • 58. Sensitivity to dexamethasone and absence of bcl-2 protein in Burkitt's lymphoma cell line (Black93) derived from a patient with acute tumor lysis syndrome: comparative study with other BL and non-BL lines.
    Tani A, Tatsumi E, Nakamura F, Kumagai S, Kosaka Y, Sano K, Nakamura H, Amakawa R, Ohno H.
    Leukemia; 1996 Oct 01; 10(10):1592-603. PubMed ID: 8847894
    [Abstract] [Full Text] [Related]

  • 59. Heterogeneity within the Epstein-Barr virus nuclear antigen 2 gene in different strains of Epstein-Barr virus.
    Aitken C, Sengupta SK, Aedes C, Moss DJ, Sculley TB.
    J Gen Virol; 1994 Jan 01; 75 ( Pt 1)():95-100. PubMed ID: 8113744
    [Abstract] [Full Text] [Related]

  • 60. Low expression of lymphocyte function-associated antigen (LFA)-1 and LFA-3 adhesion molecules is a common trait in Burkitt's lymphoma associated with and not associated with Epstein-Barr virus.
    Billaud M, Rousset F, Calender A, Cordier M, Aubry JP, Laisse V, Lenoir GM.
    Blood; 1990 May 01; 75(9):1827-33. PubMed ID: 1691936
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.